GO:0005546 phosphatidylinositol-4,5-bisphosphate binding: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0005546 describes the molecular function of binding to phosphatidylinositol-4,5-bisphosphate (PIP2), a phosphoinositide that acts as both a membrane anchor and a signaling lipid.
PIP2 binding controls ion channel gating, vesicle exocytosis, cytoskeletal remodeling, and host-pathogen interactions.
PIP2 is generated primarily by PIP5K enzymes and is enriched in the plasma membrane, where it recruits and activates effector proteins.
Dysregulated PIP2 binding contributes to channelopathies, infectious disease susceptibility, and cancer-associated signaling.
CRISPR knockout, point-mutation, and knock-in models are essential to dissect PIP2-binding site function in candidate proteins.
EDITGENE provides end-to-end CRISPR cell model and screening services to study PIP2-binding proteins at scale.

Description

Phosphatidylinositol-4,5-bisphosphate (PIP2) is a minor but critically important phospholipid of the inner leaflet of the plasma membrane. The Gene Ontology molecular function term GO:0005546, phosphatidylinositol-4,5-bisphosphate binding, describes the selective interaction of a protein with this lipid. PIP2 binding is not merely a passive membrane tether; it is a regulated event that changes protein conformation, localization, and activity. For researchers, GO:0005546 provides a precise annotation for proteins whose function depends on PIP2, including ion channels, cytoskeletal regulators, and trafficking machinery. Understanding this term is therefore central to membrane biology, signal transduction, and drug discovery.

phosphatidylinositol-4,5-bisphosphate binding At A Glance

GO ID GO:0005546
GO term phosphatidylinositol-4,5-bisphosphate binding
Ontology molecular_function
Synonym PIP2 binding; PtdIns(4,5)P2 binding; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate binding
Major function Recruitment and regulation of proteins at PIP2-enriched membranes
Lipid ligand Phosphatidylinositol-4,5-bisphosphate (PIP2)
Subcellular context Plasma membrane, endosomes, and other PIP2-containing membranes
Representative proteins KCNQ5, TMEM16A, beta-arrestin-2, formins, ARP2/3 regulators
Related processes Ion transport, exocytosis, actin nucleation, pathogen uptake

What Is GO:0005546?

GO:0005546 is defined by QuickGO as the binding to phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4-prime and 5-prime positions. In practical terms, it is the molecular function of a protein domain or surface patch that recognizes the headgroup of PIP2 with sufficient affinity and specificity to mediate membrane recruitment, conformational change, or both.

Why Is phosphatidylinositol-4,5-bisphosphate binding Important in Cell Biology?

PIP2 binding is a convergence point for many cellular decisions. It determines whether an ion channel opens, whether a vesicle fuses, whether actin polymerizes, and whether a pathogen is internalized. Because PIP2 levels and availability are dynamically controlled, proteins that bind PIP2 are sensitive to signaling inputs and metabolic state. Consequently, GO:0005546 is a high-value annotation for understanding both normal physiology and disease mechanisms.
Controls ion channel activity, including KCNQ5 and TMEM16A, with direct implications for excitability and epithelial transport.
Drives regulated exocytosis, such as Weibel-Palade body release from endothelial cells.
Regulates actin nucleation through formin and ARP2/3 pathways, affecting cell shape and motility.
Mediates host cell uptake of pathogens like Staphylococcus aureus.
Modulates receptor desensitization via beta-arrestin-2 pre-activation.
Contributes to endosomal catabolism and resilience against pathogens.
Influences membrane organization, including influenza hemagglutinin-mediated PIP2 clustering.
Provides a targetable node for channelopathies, infectious disease, and cancer research.

What Happens During phosphatidylinositol-4,5-bisphosphate binding?

Membrane recruitment and local enrichment
In simple terms: Proteins find PIP2 in the membrane and stick to it.
PIP2 is concentrated in specific membrane microdomains, and proteins with PIP2-binding domains are recruited to these regions. This recruitment is the first step in PIP2-dependent signaling and can be modulated by lateral distribution of the lipid.
Conformational change and activation
In simple terms: Binding to PIP2 can flip a protein into its active shape.
For many proteins, PIP2 binding induces a conformational change that relieves autoinhibition or stabilizes an active state. For example, beta-arrestin-2 undergoes pre-activation upon PIP2 binding, and KCNQ5 channels are activated by PIP2 through a specific mechanism.
Functional output: channels, trafficking, and cytoskeleton
In simple terms: Once bound, the protein does its job, such as opening a channel or moving vesicles.
PIP2 binding directly regulates ion channel gating, vesicle exocytosis, and actin nucleation. Wasted TMEM16A channels can be rescued by PIP2, and Weibel-Palade body exocytosis requires plasma membrane PIP2. Formin- and ARP2/3-mediated actin nucleation is also controlled by PIP2 distribution.
Pathogen exploitation and immune defense
In simple terms: Some bacteria use PIP2 binding to enter cells, while cells use PIP2 to defend themselves.
PIP5KIgamma90-generated PIP2 promotes Staphylococcus aureus uptake by host cells, illustrating how pathogens hijack PIP2 binding. Conversely, endosomal catabolism of PIP2 is fundamental for building resilience against pathogens.

Key Genes Involved in GO:0005546 phosphatidylinositol-4,5-bisphosphate binding

The following genes and proteins are representative of PIP2-binding functions and are widely studied in the context of GO:0005546.
GeneMajor RoleResearch Relevance
KCNQ5PIP2-activated potassium channelNeuronal excitability and channelopathy models
TMEM16APIP2-regulated chloride channelEpithelial secretion and rescue of trafficking mutants
ARRB2Beta-arrestin-2, PIP2-dependent pre-activationGPCR desensitization and signaling
PIP5K1CPIP5KIgamma90, generates PIP2Host-pathogen uptake and membrane dynamics
FMN1Formin, PIP2-regulated actin nucleationCytoskeletal remodeling
ARP2/3 complexActin nucleation downstream of PIP2Cell motility and membrane protrusion
VWFWeibel-Palade body cargoEndothelial exocytosis requiring PIP2
RAB27AVesicle trafficking regulatorExocytosis and PIP2-dependent release
STXBP1Syntaxin-binding proteinMembrane fusion and PIP2 sensitivity
SNAP23SNARE proteinWeibel-Palade body exocytosis
HAInfluenza hemagglutininModulates PIP2 clustering
PIP5K1APIP2 synthesisMembrane phosphoinositide regulation
PIP5K1BPIP2 synthesisMembrane phosphoinositide regulation
PLCB1PIP2 hydrolysisDownstream signaling
INPP5BPIP2 dephosphorylationEndosomal catabolism
OCRLPIP2 5-phosphataseEndosomal trafficking and pathogen defense
SYNJ1PIP2 phosphataseSynaptic vesicle recycling
ATP8A2PIP2-dependent flippaseMembrane asymmetry

How Is phosphatidylinositol-4,5-bisphosphate binding Regulated?

PIP2 binding is regulated by the availability and lateral organization of PIP2 itself. PIP5K enzymes synthesize PIP2, while phosphatases such as OCRL, INPP5B, and SYNJ1 degrade it, thereby controlling binding events. Membrane clustering of PIP2, as observed with influenza hemagglutinin, can further modulate access to binding sites. Additionally, proteins like beta-arrestin-2 can be pre-activated by PIP2, adding a layer of regulation before downstream signaling.

phosphatidylinositol-4,5-bisphosphate binding and Human Disease

GeneDisease / BiologyPotential Experimental Model
KCNQ5Channelopathy, epilepsyKnockout and point-mutation iPSC-derived neurons
TMEM16ACystic fibrosis-like secretion defectsKnock-in of trafficking mutants in epithelial cells
ARRB2GPCR signaling disordersOverexpression and KO in HEK293 cells
PIP5K1CBacterial infection susceptibilityKO in macrophages and infection assays
OCRLLowe syndrome, endosomal traffickingKnockout in fibroblasts and endosomal catabolism assays
Channelopathies and neurological disorders
Mutations in PIP2-binding channels such as KCNQ5 can alter neuronal excitability, and impaired PIP2 regulation is linked to channelopathies. TMEM16A trafficking defects that cause disease can be rescued by PIP2, suggesting therapeutic potential.
Infectious disease
PIP2 binding is exploited by Staphylococcus aureus for host cell uptake, and endosomal PIP2 catabolism is critical for defense against pathogens. This makes PIP2-binding proteins potential targets for anti-infective strategies.
Cancer and cell motility
PIP2-regulated actin nucleation via formins and ARP2/3 influences cell migration and invasion, processes central to cancer metastasis. Dysregulated PIP2 signaling can therefore contribute to tumor progression.
Vascular and inflammatory disorders
Weibel-Palade body exocytosis, which requires plasma membrane PIP2, is essential for endothelial hemostasis and inflammation. Defects in this process can lead to bleeding or thrombotic disorders.

From phosphatidylinositol-4,5-bisphosphate binding-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of PIP2 binding affect channel activity?CRISPR knockout of KCNQ5 in neurons
Can a point mutation abolish PIP2 sensitivity?Point-mutation knock-in of KCNQ5 or TMEM16A
Does PIP2 binding regulate exocytosis?Knockout of PIP5K1C in endothelial cells
How does PIP2 binding affect pathogen uptake?CRISPR KO of PIP5K1C in macrophages
Does PIP2 binding control actin nucleation?Knockout of FMN1 or ARP2/3 subunits
Can PIP2 binding be visualized in live cells?Tagged knock-in of PIP2-binding proteins

How to Study the phosphatidylinositol-4,5-bisphosphate binding Process

MethodWhat It MeasuresTypical Application
Lipid overlay assayDirect PIP2 bindingScreening protein domains
Surface plasmon resonanceBinding affinity and kineticsQuantifying PIP2-protein interactions
FRET imagingReal-time PIP2 bindingLive-cell membrane dynamics
Patch-clampChannel activityPIP2 regulation of KCNQ5/TMEM16A
CRISPR knockout screenGenes required for PIP2-dependent processesPathogen uptake and actin nucleation
Mass spectrometryProtein interactions and modificationsIdentifying PIP2-binding complexes
Live-cell TIRF microscopyMembrane clusteringPIP2 microdomain analysis
Lipid-protein interaction assays
PIP2 binding can be measured using lipid overlay assays, surface plasmon resonance, or isothermal titration calorimetry with PIP2-containing liposomes. These methods quantify affinity and specificity of candidate proteins.
Live-cell imaging and FRET
Genetically encoded PIP2 sensors and FRET-based reporters allow real-time visualization of PIP2 distribution and binding dynamics at the plasma membrane and endosomes.
Electrophysiology
Patch-clamp recordings are used to assess PIP2-dependent regulation of ion channels such as KCNQ5 and TMEM16A, including rescue of mutant channels.
CRISPR screening and proteomics
Genome-wide CRISPR knockout screens combined with mass spectrometry can identify genes and proteins that regulate PIP2 binding and downstream processes.

How CRISPR Can Be Used to Study GO:0005546 phosphatidylinositol-4,5-bisphosphate binding

Knockout

CRISPR knockout of genes encoding PIP2-binding proteins or PIP2-synthesizing enzymes (e.g., PIP5K1C) can reveal loss-of-function phenotypes in exocytosis, pathogen uptake, and channel activity.

Point Mutation

Introducing point mutations in PIP2-binding sites (e.g., in KCNQ5 or TMEM16A) allows precise testing of whether lipid binding is required for protein function.

Knock-in

Knock-in of tagged or disease-associated variants (e.g., fluorescently tagged beta-arrestin-2) enables tracking of PIP2-dependent localization and activation in live cells.

Overexpression

Overexpression of PIP2-binding proteins or PIP2 sensors can amplify signaling and facilitate biochemical detection of binding events.

How EDITGENE Supports phosphatidylinositol-4,5-bisphosphate binding Research

Researchers studying phosphatidylinositol-4,5-bisphosphate binding-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease phenotype. EDITGENE provides validated CRISPR cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol-4,5-bisphosphate binding research.

Frequently Asked Questions About phosphatidylinositol-4,5-bisphosphate binding

It is the molecular function defined by GO:0005546, where a protein selectively binds to the lipid PIP2, often at the plasma membrane.
Key genes include KCNQ5, TMEM16A, ARRB2, PIP5K1C, and FMN1, among others.
PIP2 binding can induce conformational changes that open or stabilize channels such as KCNQ5 and TMEM16A.
Plasma membrane PIP2 promotes Weibel-Palade body exocytosis in endothelial cells.
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect PIP2-binding functions.
Channelopathies, infectious diseases, cancer, and vascular disorders have been associated with PIP2-binding proteins.
Common methods include lipid overlay assays, surface plasmon resonance, FRET imaging, and patch-clamp electrophysiology.
PIP2 is phosphorylated at the 4 and 5 positions of the inositol ring, while PIP3 has an additional phosphate at position 3; they have distinct binding partners.
Yes, lateral distribution and clustering of PIP2 in membranes can regulate access to binding sites.
EDITGENE offers CRISPR point-mutation and knockout services to generate precisely modified cell lines for PIP2 research.

Conclusion

GO:0005546 phosphatidylinositol-4,5-bisphosphate binding is a fundamental molecular function that connects lipid signaling to ion transport, vesicle trafficking, cytoskeletal dynamics, and host-pathogen interactions. Its dysregulation is implicated in a range of diseases, making it a compelling target for basic and translational research. By leveraging CRISPR cell models and screening technologies, researchers can systematically dissect the roles of PIP2-binding proteins and accelerate therapeutic discovery.

References

  1. 1. Yang Z et al.. 2025. Phosphatidylinositol 4,5-bisphosphate activation mechanism of human KCNQ5.. Proc Natl Acad Sci U S A 122(14):e2416738122 PMID: 40172963
  2. 2. Nguyen TTN et al.. 2020. Plasma membrane phosphatidylinositol (4,5)-bisphosphate promotes Weibel-Palade body exocytosis.. Life Sci Alliance 3(11) PMID: 32826291
  3. 3. Shi Y et al.. 2021. PIP5KIγ90-generated phosphatidylinositol-4,5-bisphosphate promotes the uptake of Staphylococcus aureus by host cells.. Mol Microbiol 116(5):1249-1267 PMID: 34519119
  4. 4. Arreola J et al.. 2019. Wasted TMEM16A channels are rescued by phosphatidylinositol 4,5-bisphosphate.. Cell Calcium 84:102103 PMID: 31683182
  5. 5. Kim K et al.. 2024. Molecular mechanism of β-arrestin-2 pre-activation by phosphatidylinositol 4,5-bisphosphate.. EMBO Rep 25(10):4190-4205 PMID: 39242774
  6. 6. Yang C et al.. 2025. Endosomal catabolism of phosphatidylinositol 4,5-bisphosphate is fundamental in building resilience against pathogens.. Protein Cell 16(3):161-187 PMID: 39087719
  7. 7. Bucki R et al.. 2019. Lateral distribution of phosphatidylinositol 4,5-bisphosphate in membranes regulates formin- and ARP2/3-mediated actin nucleation.. J Biol Chem 294(12):4704-4722 PMID: 30692198
  8. 8. Curthoys NM et al.. 2019. Influenza Hemagglutinin Modulates Phosphatidylinositol 4,5-Bisphosphate Membrane Clustering.. Biophys J 116(5):893-909 PMID: 30773293
Contact Us
*
*
*
*
How did you hear about us: